Pfizer Q3 Preview: Why The Stock Is A Buy Ahead Of Earnings

I initiated coverage on Pfizer (NYSE: PFE ) stock with a "Buy" rating, stating that the company's low valuation and strong product pipeline make it the ultimate buying opportunity for income investors in the healthcare sector. In early May, IHe leads the investing group Beyond the Wall Investing with features that include: a fundamentals-based portfolio, weekly analysis on insights from institutional investors, regular alerts for short-term trade ideas based on technical signals, ticker feedback by request ...